U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281326) titled 'A Study of AK138D1 in Advanced Malignant Tumors' on Sept. 25.
Brief Summary: This is a Phase I clinical trial testing the safety and effectiveness of AK138D1in patients with advanced cancer. The study will enroll up to 200 patients with various types of advanced solid tumors who haven't responded to standard treatments. Patients will receive AK138D1 to determine the safest dose and evaluate if the drug can help treat their cancer.
Study Start Date: Oct. 22
Study Type: INTERVENTIONAL
Condition:
Solid Cancer
Intervention:
DRUG: AK138D1
Enrolled subjects will receive intravenous infusion (IV) of AK138D1 according to the dosing r...